MHRA Seeks Input on Prioritisation of Designated Standards

9th September 2025

MHRA Seeks Input on Prioritisation of Designated Standards

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a call for evidence to gather stakeholder views on the prioritisation of designated standards under the UK Medical Devices Regulations.

The consultation aims to identify which standards are most critical for ensuring device safety, performance, and regulatory compliance. Feedback will help the MHRA focus resources on the most important standards, supporting innovation and patient safety while maintaining efficient regulatory oversight. Stakeholders are encouraged to respond to the survey to guide future decisions on standard prioritisation.

Designated Standards Prioritisation – Call for Evidence

Back to Recent News